Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Timothy Norris"'
Autor:
Michael Rowe, Ayesha Hidayat, Timothy Norris, Adam Pollard, John McGrane, Alastair Thomson, Stuart Walter, Deborah Victor
Publikováno v:
Journal of Clinical Urology. 15:257-263
Objective: Enzalutamide is effective in treating metastatic castrate-resistant prostate cancer (mCRPC) but can have side effects that require treatment breaks (TB). We conducted a retrospective analysis of outcomes of patients who had extended TB due
Autor:
John McGrane, Michael Rowe, Stuart Walter, Ayesha Hidayat, Hannah Donkers, Andrew Browne, Timothy Norris, Adam Pollard, Deborah Victor
Publikováno v:
Clinical Oncology and Research. :1-6
Background: We investigated our institution’s mCRPC enzalutamide or abiraterone patients examining PSA responses and impact of sequencing of these drugs. Methods: All enzalutamide / abiraterone mCRPC patients (2011-2018) were included. Rates of PSA
Publikováno v:
Journal of immunotherapy (Hagerstown, Md. : 1997). 44(4)
Pembrolizumab is an anti-programmed cell death protein 1 immune checkpoint inhibitor with a dosing schedule of 200 mg 3 weekly (q3w). Dose of 400 mg 6 weekly (q6w) was approved based on simulation of dose/exposure relationships and predicted no diffe
Autor:
Deborah Victor, Ayesha Hidayat, S Walter, Timothy Norris, Adam Pollard, John McGrane, Michael Rowe
Publikováno v:
Clinical oncology (Royal College of Radiologists (Great Britain)). 33(1)
Autor:
Stuart Walter, Deborah Victor, Adam Pollard, Alastair Thomson, Michael Rowe, Timothy Norris, Ayesha Hidayat, John McGrane
Publikováno v:
Journal of Clinical Oncology. 38:81-81
81 Background: Intermittent hormone manipulation in castrate-sensitive prostate cancer can improve quality of life whilst maintaining comparable disease outcomes with continuous scheduling. Enzalutamide is effective in metastatic castrate-resistant p
Publikováno v:
Organic Process Research & Development. 13:354-357
A green chemistry methodology that uses a heavy-metal-free reduction in aqueous medium is described to produce 5-hydrazinoquinoline [1-(quinolin-5-yl)hydrazine] (6a) as the anhydrous dihydrochloride salt at large scale. The process is entirely aqueou
Autor:
Marcus Ewing, Stephen E. Hubbs, John VanAlsten, Timothy Norris, Grace O. Jensen, Matthew L. Jorgensen, Weiling Cai, Jon Bordner
Publikováno v:
Organic Process Research & Development. 12:447-455
Many years ago anidulafungin 1 was identified as a potentially useful medicine for the treatment of fungal infections. Its chemical and physical properties as a relatively high molecular weight semisynthetic derived from echinocandin B proved to be a
Publikováno v:
Organic Process Research & Development. 11:742-746
A process has been developed for the use of trimethylphosphite for the formation of the six-membered 3,6-dihydro-2H-[1,3]thiazine ring in the cephem architecture by an intramolecular Horner−Emmons−...
Publikováno v:
Organic Process Research & Development. 9:792-799
Prodrugs derived from the β-lactamase inhibitor 6-β-hydroxymethylsulbactam can be synthesized efficiently in a three-step process by making use of the highly stereoselective radical debromination utilizing tri-n-butylgermanium hydride. This reagent
Autor:
Paul Ahlijanian, Jeroen Konings, Roberto Colon-Cruz, Dominique Monique Char Callant, Ben de Lange, Robert de Pater, Joel M. Hawkins, Lulin Wei, Jean Andrien, Jennifer Lea Rutherford, Kurt Stickley, Jos Hulshof, Peter Johannes Dominicus Maas, Timothy Norris, Roel Vollinga, Mark T. Barrila, David W. L. Sung, Michel Couturier, and Natalka Johnson, Ioulia V. Loubkina, Elena Daia, Brian M. Andresen, David H. Brown Ripin, Jos Versleijen
Publikováno v:
Organic Process Research & Development. 9:432-439
The optimization of the synthesis of 6β-hydroxymethylsulbactam is described. The primary challenge in this synthesis is the installation of the 6β-hydroxymethyl group with the proper stereochemistry. Engineering challenges associated with the addit